Correlation Between Mydecine Innovations and Decibel Cannabis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Decibel Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Decibel Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mydecine Innovations Group and Decibel Cannabis, you can compare the effects of market volatilities on Mydecine Innovations and Decibel Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Decibel Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Decibel Cannabis.

Diversification Opportunities for Mydecine Innovations and Decibel Cannabis

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Mydecine and Decibel is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Decibel Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Decibel Cannabis and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Decibel Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Decibel Cannabis has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Decibel Cannabis go up and down completely randomly.

Pair Corralation between Mydecine Innovations and Decibel Cannabis

Assuming the 90 days horizon Mydecine Innovations Group is expected to generate 11.82 times more return on investment than Decibel Cannabis. However, Mydecine Innovations is 11.82 times more volatile than Decibel Cannabis. It trades about 0.12 of its potential returns per unit of risk. Decibel Cannabis is currently generating about -0.01 per unit of risk. If you would invest  9.50  in Mydecine Innovations Group on September 4, 2024 and sell it today you would lose (9.00) from holding Mydecine Innovations Group or give up 94.74% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.19%
ValuesDaily Returns

Mydecine Innovations Group  vs.  Decibel Cannabis

 Performance 
       Timeline  
Mydecine Innovations 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.
Decibel Cannabis 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Decibel Cannabis are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Decibel Cannabis reported solid returns over the last few months and may actually be approaching a breakup point.

Mydecine Innovations and Decibel Cannabis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mydecine Innovations and Decibel Cannabis

The main advantage of trading using opposite Mydecine Innovations and Decibel Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Decibel Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decibel Cannabis will offset losses from the drop in Decibel Cannabis' long position.
The idea behind Mydecine Innovations Group and Decibel Cannabis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities